Cala lands $77M for neuromodulation therapy; aptihealth rakes in $50M for behavioral health

Cala Health, maker of wearable neuromodulation therapy, scored $77 million in new funding led by Ascension Ventures. Dolby Family Ventures, PEAK6 Strategic Capital and Innovatus Capital Partners also participated in the funding round.

This news comes roughly two and a half years after the company closed its $55 million Series B round.

The company is working on technology to help ease tremors by delivering “individualized peripheral nerve stimulation.” The company is currently working on therapies for neurology, cardiology and psychiatry. In 2018, the company landed FDA clearance for its prescription neuromodulation therapy for tremor relief. 

The infusion of cash is expected to help the company explore beyond tremors and into neurological indications including Parkinson’s. It will also go towards developing tools in the psychiatry, cardiology and autoimmune disorder spaces. 

Digital behavioral health company aptihealth scooped up $50 million in Series B funding. Takeda Digital Ventures, Pivotal Life Sciences, Vista Credit Partners, Olive Tree Ventures, Claritas Capital and What if Ventures participated in this round of funding. 

The Boston-based startup works with health plans and health systems to integrate mental healthcare into their system. Patients are able to get a personalized plan, video therapy that can be scheduled online and, if on medications, management advice from a psychiatrist prescriber. Members are able to message with their therapist outside of sessions and get support around the clock. The tool was also designed to help with care coordination. 

The company plans to use the new funds to build out its clinical science, technology and services. 

Remote care company MedArrive scored $25 million in Series A funding this morning. The round was led by Section 32 with participation from 7wireVentures, Leaps by Bayer, Define Ventures, Kleiner Perkins and Redesign Health. 

MedArrive is focused on transitioning patient care into the home by combining a software platform with field clinicians. Healthcare providers or health plans are able to use the platform to request a field provider — who could be an EMT, a registered nurse, a phlebotomist or another practitioner — to come into the patient’s home for a service.

As well as performing a clinical service, these practitioners are also able to collect social determinants of health data and enter it in the platform. 

As part of the new financing round, Andy Harrison, managing partner at Section 32, will join the board of directors. The company plans to use the new money to expand its network into new states and build out its team. 

Digital prenatal and postpartum care company Marani Health landed $7.6 million in seed funding earlier this week. One AlphaNorth Capital, SWL Healthcare Ventures and TFX Capital participated in this investment round. 

Marani combines its consumer app called M•other with its clinical portal. The platform is able to capture data wirelessly and send it to a patient and provider portal. The idea is to provide clinicians with more insights into a patient’s condition at home. 

The company plans to use the new funds to launch its platform. 

LifeVoxel.AI, maker of an artificial intelligence tool for healthcare, scored $5 million in seed funding. The San Diego-based company created immersive virtual 3D models of patient data. The company’s imaging technology, Prescient, allows clinicians to view medical images interactively in real time. Doctors can also get access to imaging studies. 

The tool is also designed to store images, diagnostic annotations, reports and data.

“Medical imaging and radiology needs dynamic solutions to replace the inadequacies in conventional systems. With this round of funding, we will be able to accelerate not only our vision to be the de facto platform for medical imaging applications across the globe but make significant strides in the Telehealth imaging and advanced tech-based AI solutions for the future of healthcare,” Sekhar Puli, co-founder, president and CEO of LifeVoxel.AI, said. 

Source link